These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 8805247)

  • 61. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Allele-specific peptide ligand motifs of HLA-C molecules.
    Falk K; Rötzschke O; Grahovac B; Schendel D; Stevanović S; Gnau V; Jung G; Strominger JL; Rammensee HG
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12005-9. PubMed ID: 8265661
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.
    Malcherek G; Falk K; Rötzschke O; Rammensee HG; Stevanović S; Gnau V; Jung G; Melms A
    Int Immunol; 1993 Oct; 5(10):1229-37. PubMed ID: 8268130
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.
    Lauterbach N; Wieten L; Popeijus HE; Voorter CE; Tilanus MG
    Hum Immunol; 2015 Aug; 76(8):578-86. PubMed ID: 26382247
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry.
    Lorente E; Marcilla M; de la Sota PG; Quijada-Freire A; Mir C; López D
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Complexity among constituents of the HLA-B*1501 peptide motif.
    Prilliman KR; Lindsey M; Jackson KW; Cole J; Bonner R; Hildebrand WH
    Immunogenetics; 1998 Jul; 48(2):89-97. PubMed ID: 9634472
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comprehensive analysis of peptides presented by HLA-A1.
    Giam K; Ayala-Perez R; Illing PT; Schittenhelm RB; Croft NP; Purcell AW; Dudek NL
    Tissue Antigens; 2015 Jun; 85(6):492-6. PubMed ID: 25880248
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.
    van Ham SM; Grüneberg U; Malcherek G; Bröker I; Melms A; Trowsdale J
    J Exp Med; 1996 Nov; 184(5):2019-24. PubMed ID: 8920889
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cells.
    Guillard C; Zidi I; Marcou C; Menier C; Carosella ED; Moreau P
    Mol Immunol; 2008 Jan; 45(2):419-27. PubMed ID: 17675239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules.
    Schild H; Grüneberg U; Pougialis G; Wallny HJ; Keilholz W; Stevanović S; Rammensee HG
    Int Immunol; 1995 Dec; 7(12):1957-65. PubMed ID: 8746565
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands.
    Perez MAS; Bassani-Sternberg M; Coukos G; Gfeller D; Zoete V
    Front Immunol; 2019; 10():2731. PubMed ID: 31824508
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HLA-E: a novel player for histocompatibility.
    Kraemer T; Blasczyk R; Bade-Doeding C
    J Immunol Res; 2014; 2014():352160. PubMed ID: 25401109
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis.
    Gays F; Fraser KP; Toomey JA; Diamond AG; Millrain MM; Dyson PJ; Brooks CG
    J Immunol; 2001 Feb; 166(3):1601-10. PubMed ID: 11160201
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules.
    Poláková K; Bennink JR; Yewdell JW; Bystrická M; Bandzuchová E; Russ G
    Hum Immunol; 2003 Feb; 64(2):256-64. PubMed ID: 12559628
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HLA-G and immune tolerance in pregnancy.
    Hunt JS; Petroff MG; McIntire RH; Ober C
    FASEB J; 2005 May; 19(7):681-93. PubMed ID: 15857883
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function.
    Gonen-Gross T; Achdout H; Gazit R; Hanna J; Mizrahi S; Markel G; Goldman-Wohl D; Yagel S; Horejsí V; Levy O; Baniyash M; Mandelboim O
    J Immunol; 2003 Aug; 171(3):1343-51. PubMed ID: 12874224
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.
    Bergseng E; Dørum S; Arntzen MØ; Nielsen M; Nygård S; Buus S; de Souza GA; Sollid LM
    Immunogenetics; 2015 Feb; 67(2):73-84. PubMed ID: 25502872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.